Hepatitis Monthly

Published by: Kowsar

Estimated Glomerular Filtration Rate Increases in Chronic Hepatitis B Patients Treated With Telbivudine Monotherapy and Combination Treatment

Libin Jiang 1 , Song Hu 1 , Man He 1 and Deying Tian 1 , *
Authors Information
1 Department of Gastroenterology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Article information
  • Hepatitis Monthly: January 2016, 16 (1); e32528
  • Published Online: January 23, 2016
  • Article Type: Research Article
  • Received: August 18, 2015
  • Revised: November 23, 2015
  • Accepted: November 23, 2015
  • DOI: 10.5812/hepatmon.32528

To Cite: Jiang L, Hu S, He M, Tian D. Estimated Glomerular Filtration Rate Increases in Chronic Hepatitis B Patients Treated With Telbivudine Monotherapy and Combination Treatment, Hepat Mon. 2016 ;16(1):e32528. doi: 10.5812/hepatmon.32528.

Copyright: Copyright © 2016, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited..
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. European Association For The Study Of The L. EASL clinical practice guidelines: Management of chronic hepatitis B virus infection. J Hepatol. 2012; 57(1): 167-85[DOI][PubMed]
  • 2. Liaw YF, Leung N, Kao JH, Piratvisuth T, Gane E, Han KH, et al. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update. Hepatol Int. 2008; 2(3): 263-83[DOI][PubMed]
  • 3. Papatheodoridis GV, Manolakopoulos S, Dusheiko G, Archimandritis AJ. Therapeutic strategies in the management of patients with chronic hepatitis B virus infection. Lancet Infect Dis. 2008; 8(3): 167-78[DOI][PubMed]
  • 4. Fontana RJ. Side effects of long-term oral antiviral therapy for hepatitis B. Hepatology. 2009; 49(5 Suppl)-95[DOI][PubMed]
  • 5. Izzedine H, Isnard-Bagnis C, Hulot JS, Vittecoq D, Cheng A, Jais CK, et al. Renal safety of tenofovir in HIV treatment-experienced patients. AIDS. 2004; 18(7): 1074-6[PubMed]
  • 6. Hadziyannis SJ, Tassopoulos NC, Heathcote EJ, Chang TT, Kitis G, Rizzetto M, et al. Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B. N Engl J Med. 2005; 352(26): 2673-81[DOI][PubMed]
  • 7. Lampertico P, Vigano M, Manenti E, Iavarone M, Sablon E, Colombo M. Low resistance to adefovir combined with lamivudine: a 3-year study of 145 lamivudine-resistant hepatitis B patients. Gastroenterology. 2007; 133(5): 1445-51[DOI][PubMed]
  • 8. Nelson MR, Katlama C, Montaner JS, Cooper DA, Gazzard B, Clotet B, et al. The safety of tenofovir disoproxil fumarate for the treatment of HIV infection in adults: the first 4 years. AIDS. 2007; 21(10): 1273-81[DOI][PubMed]
  • 9. Mauss S, Berger F, Schmutz G. Antiretroviral therapy with tenofovir is associated with mild renal dysfunction. AIDS. 2005; 19(1): 93-5[PubMed]
  • 10. Gane EJ, Deray G, Liaw YF, Lim SG, Lai CL, Rasenack J, et al. Telbivudine improves renal function in patients with chronic hepatitis B. Gastroenterology. 2014; 146(1): 138-146 e5[DOI][PubMed]
  • 11. Cholongitas E, Vasiliadis T, Goulis I, Fouzas I, Antoniadis N, Papanikolaou V, et al. Telbivudine is associated with improvement of renal function in patients transplanted for HBV liver disease. J Viral Hepat. 2015; 22(7): 574-80[DOI][PubMed]
  • 12. Amet S, Bronowicki JP, Thabut D, Zoulim F, Bourliere M, Mathurin P, et al. Prevalence of renal abnormalities in chronic HBV infection: the HARPE study. Liver Int. 2015; 35(1): 148-55[DOI][PubMed]
  • 13. Bhimma R, Coovadia HM. Hepatitis B virus-associated nephropathy. Am J Nephrol. 2004; 24(2): 198-211[DOI][PubMed]
  • 14. Zou XJ, Jiang XQ, Tian DY. Clinical features and risk factors of creatine kinase elevations and myopathy associated with telbivudine. J Viral Hepat. 2011; 18(12): 892-6[DOI][PubMed]
  • 15. Hsu HC, Lin GH, Chang MH, Chen CH. Association of hepatitis B surface (HBs) antigenemia and membranous nephropathy in children in Taiwan. Clin Nephrol. 1983; 20(3): 121-9[PubMed]
  • 16. Tang S, Lai FM, Lui YH, Tang CS, Kung NN, Ho YW, et al. Lamivudine in hepatitis B-associated membranous nephropathy. Kidney Int. 2005; 68(4): 1750-8[DOI][PubMed]
  • 17. Lai CL, Gane E, Liaw YF, Hsu CW, Thongsawat S, Wang Y, et al. Telbivudine versus lamivudine in patients with chronic hepatitis B. N Engl J Med. 2007; 357(25): 2576-88[DOI][PubMed]
  • 18. Peng CY, Chien RN, Liaw YF. Hepatitis B virus-related decompensated liver cirrhosis: benefits of antiviral therapy. J Hepatol. 2012; 57(2): 442-50[DOI][PubMed]
  • 19. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003; 139(2): 137-47[PubMed]
  • 20. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro A3, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009; 150(9): 604-12[PubMed]
  • 21. Ha NB, Ha NB, Garcia RT, Trinh HN, Vu AA, Nguyen HA, et al. Renal dysfunction in chronic hepatitis B patients treated with adefovir dipivoxil. Hepatology. 2009; 50(3): 727-34[DOI][PubMed]
  • 22. Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med. 2004; 164(6): 659-63[DOI][PubMed]
  • 23. Liang KH, Chen YC, Hsu CW, Chang ML, Yeh CT. Decrease of serum Angiotensin converting enzyme levels upon telbivudine treatment for chronic hepatitis B virus infection and negative correlations between the enzyme levels and estimated glumerular filtration rates. Hepat Mon. 2014; 14(1)[DOI][PubMed]
  • 24. Tanji N, Tanji K, Kambham N, Markowitz GS, Bell A, D'Agati V D. Adefovir nephrotoxicity: possible role of mitochondrial DNA depletion. Hum Pathol. 2001; 32(7): 734-40[DOI][PubMed]
  • 25. Thurairajah P, Khanna A, Mutimer D. Add-on combination therapy with adefovir dipivoxil induces renal impairment in patients with lamivudine-refractory hepatitis B virus (J Viral Hepat 2010 Feb 1;17(2):123-9). J Viral Hepat. 2011; 18(11): 820[DOI][PubMed]
  • 26. Yang YF, Xiong QF, Zhao W, Zhong YD. Complete remission of hepatitis B virus-related membranous nephropathy after entecavir monotherapy. Clin Res Hepatol Gastroenterol. 2012; 36(5)-92[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader